InterVenn Investigator Initiated Research Program in Glycoproteomics

"Peripheral Blood Glycoproteomic Biomarkers As A Powerful New Tool For The Detection Of Nasopharyngeal Carcinoma"

— Association for Cancer Research (AACR) 2022 , Abstract

"Glycoproteomics-based Liquid Biopsy Informs Optimal Checkpoint-inhibitor Drug Choice"

— Association for Cancer Research (AACR) 2022 , Abstract

"Novel Plasma Glycoprotein Biomarkers Predict Progression-Free Survival In Surgically Resected Clear Cell Renal Cell Carcinoma"

— Urologic Oncology: Seminars and Original Investigations

"Differential Peripheral Blood Glycoprotein Profiles In Symptomatic And Asymptomatic COVID-19"

— Viruses

"30 Blood-Based Glycoprotein Signatures In Advanced Non-Small-Cell Lung Carcinoma (NSCLC) Receiving First-Line Immune Checkpoint Blockade"

— BMJ Publishing Group Ltd

"Differential Glycoprotein Profiles In Severe And Asymptomatic COVID-19"

— American Society for Mass Spectrometry, 2021

"Serum Glycoprotein Markers In Non-Alcoholic Steatohepatitis And Hepatocellular Carcinoma"

— bioRxiv

"Glycoproteomics As A Powerful Liquid Biopsy-Based Predictor Of Checkpoint-Inhibitor Treatment Response"

— American Association for Cancer Research

"Site-Specific Glycosylation Quantitation Of 50 Serum Glycoproteins Enhanced By Predictive Glycopeptidomics For Improved Disease Biomarker Discovery"

— Analytical Chemistry, 2019

"PB-Net: Automatic Peak Integration By Sequential Deep Learning For Multiple Reaction Monitoring"

— ScienceDirect

"Serum Glycoproteomic-Based Liquid Biopsy For The Detection Of Pancreatic Ductal Adenocarcinoma."

— Journal of Clinical Oncology